Limb salvage by neoadjuvant isolated perfusion with TNFα and melphalan for non-resectable soft tissue sarcoma of the extremities

European Journal of Surgical Oncology

Volumn 26, Issue 7, 2000, Pages 669-678

  Lejeune, F J ^a   Pujol, N ^a   Lienard D ^a   Mosimann, F ^a   Raffoul, W ^a   Genton, A ^a   Guillou, L ^a   Landry, M ^a   Chassot, P G ^a   Chiolero, R ^a   Bischof Delaloye, A ^a   Leyvraz, S ^a   Mirimanoff, R O ^a   Bejkos, D ^b   Leyvraz, P F ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EORTC DATA CENTER   (Belgium)

Author keywords

Isolated limb perfusion; Neoadjuvant; Soft tissue sarcomas; TNF

Indexed keywords

GAMMA INTERFERON; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOSARCOMA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; FEVER; HUMAN; INOPERABLE CANCER; LEIOMYOSARCOMA; LIMB PERFUSION; LIMB SALVAGE; LIPOSARCOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; NERVE SHEATH TUMOR; OSTEOSARCOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SHOCK; SOFT TISSUE SARCOMA;

EID: 0033636988     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.0979     Document Type: Article

References (33)

1. Local recurrence and survival in soft-tissue sarcomas
2. Adult soft tissue sarcoma
3. The changing role of amputation for soft tissue sarcoma of the extremity in adults
4. Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: Implications for management
5. Results of surgery and multimodal therapy for patients with soft tissue sarcoma invading to vascular structures
6. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
7. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial
8. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience
9. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions
10. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma - Results of a multicenter randomized phase iii trial
11. Continuous leakage monitoring during hyperthermic isolated regional perfusion of the lower limb: Techniques and results
12. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults - Meta-analysis of individual data
13. WHO handbook for reporting results of cancer treatment
14. Nonparametric estimation from incomplete observations
15. Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan
16. High Dose Tumor Necrosi Factor alpha and melphalan administered via Isolated Limb Perfusion for advanced limb soft tissue sarcoma results in a >90% Response Rate and limb preservation
17. Multifocal soft tissue sarcoma: Limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalan
18. Upper and lower limb disarticulation in soft tissue and bone sarcomas
19. Prognostic factors in adult patients with locally controlled soft tissue sarcoma
20. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival
21. Is local recurrence of minor importance for metastases in soft tissue sarcoma?
22. Management of soft tissue sarcoma
23. Limb-sparing therapy for soft tissue sarcomas
24. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity
25. Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery
26. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma
27. Chemotherapy of sarcomas of the limbs by regional perfusion
28. Results of regional isolation perfusion with cytostatics in patients with sot tissue tumors of the extremities
29. High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: A model for biochemotherapy of cancer
30. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN gamma
31. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability
32. Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts